Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank description Gene Value Type Network Comparison Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 501 to 550 of 19268 in total 
Value Type: Measured

\def\wcA{0.11111111111111\textwidth}
\def\wcB{0.11111111111111\textwidth}
\def\wcC{0.11111111111111\textwidth}
\def\wcD{0.11111111111111\textwidth}
\def\wcE{0.11111111111111\textwidth}
\def\wcF{0.11111111111111\textwidth}
\def\wcG{0.11111111111111\textwidth}
\def\wcH{0.11111111111111\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
63\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related gtp binding b short isoform; gtp-binding protein ragb. [source:refseq;acc:nm\_006064]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
11681.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
10618.8\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1062.5\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3832\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
spir-2 protein (fragment). [source:sptrembl;acc:q8wwl2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
56.278\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
31.1429\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.80709\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 8 (zinc finger protein hf.18) (fragment). [source:swissprot;acc:p17098]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
1972.19\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2355.41\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
383.22\vspace{3pt}}\\\cline{1-2}\cline{4-8}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
64\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amp deaminase 2 (ec 3.5.4.6) (amp deaminase isoform l). [source:swissprot;acc:q01433]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3832\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
b-lymphocyte activation-related protein. [source:sptrembl;acc:q96pn3]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1972.04\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2355.24\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
383.2\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna helicase homolog (fragment). [source:sptrembl;acc:q9y645]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
23.6984\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
48.2534\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
2.03615\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
glycogen phosphorylase, muscle form (ec 2.4.1.1) (myophosphorylase). [source:swissprot;acc:p11217]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2765.82\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4489.19\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.6231\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-2 subunit (karyopherin alpha-2 subunit) (srp1-alpha) (rag cohort protein 1). [source:swissprot;acc:p52292]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
1068\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
607\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
461\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol-4-phosphate 3-kinase c2 domain-containing beta polypeptide (ec 2.7.1.154) (phosphoinositide 3-kinase-c2-beta) (ptdins-3-kinase c2 beta) (pi3k-c2beta) (c2-pi3k). [source:swissprot;acc:o00750]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
18\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1800000\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related gtp binding a; ras-related gtp-binding protein. [source:refseq;acc:nm\_006570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
11638.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
10585.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1053.1\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinal short-chain dehydrogenase/reductase 3. [source:refseq;acc:nm\_016246]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.13635\vspace{3pt}}\\\cline{1-2}\cline{5-8}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
65\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bet5 homolog (multiple myeloma protein 2) (mum-2). [source:swissprot;acc:q9y5r8]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
923.065\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
465.658\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.98228\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
cleavage stimulation factor subunit 3; cleavage stimulation factor, 3' pre-rna, subunit 3, 77kd. [source:refseq;acc:nm\_001326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
18702.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
22515.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3812.9\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
muscle-specific beta 1 integrin binding protein. [source:refseq;acc:nm\_014446]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
861.814\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
420.365\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
441.449\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
neuralized-like. [source:refseq;acc:nm\_004210]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2690.25\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1657.68\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.6229\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
rna helicase-related protein; rna helicase-like protein; sf3b125 dead-box protein. [source:refseq;acc:nm\_007372]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
18\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1800000\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
septin 6. [source:swissprot;acc:q14141]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
14773.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
13005.8\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.13593\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
thyroid receptor interacting protein 8 (trip-8) (fragment). [source:swissprot;acc:q15652]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
2950.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1917.64\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1032.86\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 169 (fragment). [source:swissprot;acc:q14929]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1971.82\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2355\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
383.18\vspace{3pt}}\\\cline{1-2}\cline{4-8}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
66\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14008\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
17757.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3749.5\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
fibrillin 3. [source:refseq;acc:nm\_032447]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
13809\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
14246\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
437\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
2954.24\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1921.96\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1032.28\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase subunit b17.2 (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b17.2) (ci-b17.2) (cib17.2) (13 kda differentiation-associated protein). [source:swissprot;acc:q9ui09]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
3221.38\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1991.03\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.61795\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
soluble liver antigen/liver pancreas antigen. [source:refseq;acc:nm\_153825]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
385.626\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
688.436\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.78524\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
son protein (son3) (negative regulatory element-binding protein) (nre- binding protein) (dbp-5) (bax antagonist selected in saccharomyces 1) (bass1) (protein c21orf50). [source:swissprot;acc:p18583]\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5555.81\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4900.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.13368\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosinase-related gene segment, exon 5 (fragment). [source:sptrembl;acc:q15677]\vspace{3pt}}&&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
142.981\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
271.484\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.89874\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 350; zinc-finger protein zbrk1. [source:refseq;acc:nm\_021632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
1971.32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2354.46\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
383.14\vspace{3pt}}\\\cline{1-3}\cline{6-8}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
67\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
5,6-dihydroxyindole-2-carboxylic acid oxidase precursor (ec 1.14.18.-) (dhica oxidase) (tyrosinase-related protein 1) (trp-1) (trp1) (trp) (catalase b) (glycoprotein-75) (melanoma antigen gp75). [source:swissprot;acc:p17643]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
142.417\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
270.264\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.89769\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 2 (arrestin, beta 2). [source:swissprot;acc:p32121]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
filamin a (alpha-filamin) (filamin 1) (endothelial actin-binding protein) (abp-280) (nonmuscle filamin). [source:swissprot;acc:p21333]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
898\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1603\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.78508\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
13781.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
12176.9\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.1318\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
jumonji domain containing 1; zinc finger protein; testis-specific protein a. [source:refseq;acc:nm\_018433]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
2959.19\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1927.68\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1031.51\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
purine nucleoside phosphorylase (ec 2.4.2.1) (inosine phosphorylase) (pnp). [source:swissprot;acc:p00491]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4320.09\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4755.32\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
435.23\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
14007.3\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
17756.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3749.2\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to zinc finger protein 20 (zinc finger protein kox13) (dkfzp572p0920). [source:refseq;acc:nm\_145233]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1971.25\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2354.39\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
383.14\vspace{3pt}}\\\hline
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
68\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-arrestin 1 (arrestin, beta 1). [source:swissprot;acc:p49407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
17738.6\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3742.9\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
folylpolyglutamate synthase, mitochondrial precursor (ec 6.3.2.17) (folylpoly-gamma-glutamate synthetase) (fpgs). [source:swissprot;acc:q05932]\vspace{3pt}}&&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
6019.79\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6452.66\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
432.87\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase mlrq subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-mlrq) (ci-mlrq). [source:swissprot;acc:o00483]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
734\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
394\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.86294\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein regulator of cytokinesis 1; protein regulating cytokinesis 1. [source:refseq;acc:nm\_003981]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
351.772\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
198.964\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.76802\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
17265.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
19498.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.12932\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
trypsin iii precursor (ec 3.4.21.4) (brain trypsinogen) (mesotrypsinogen) (trypsin iv). [source:swissprot;acc:p35030]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
2998.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1972.65\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1025.45\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 222. [source:swissprot;acc:q9uk12]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1971.25\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2354.39\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
383.14\vspace{3pt}}\\\cline{1-3}\cline{5-8}
\multirow{6}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
69\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amino acid transporter xat2; likely ortholog of mouse aspartate/glutamate transporter 1 (agt1). [source:refseq;acc:nm\_138817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
7848.45\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6991.78\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.12253\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g1 (cyclin g). [source:swissprot;acc:p51959]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
13995.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3742.9\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
2804\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1593\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.7602\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
phenylethanolamine n-methyltransferase (ec 2.1.1.28) (pnmtase) (noradrenaline n-methyltransferase). [source:swissprot;acc:p11086]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
139\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
570\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
431\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
spermatogenesis associated 6. [source:refseq;acc:nm\_019073]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
10307.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
6475.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.59177\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
trypsin i precursor (ec 3.4.21.4) (cationic trypsinogen). [source:swissprot;acc:p07477]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
3007.85\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1983.91\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1023.94\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/